Patients discharged with elevated baseline high-sensitive cardiac troponin T from the emergency department

Christian Bjurman1, Matteus Zywczyk2, Soza Zangana2

  • 1Department of Medicine, Sahlgrenska University Hospital at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Insights

Elevated high-sensitive cardiac troponin T (hs-cTnT) levels in emergency department patients indicate a higher risk of mortality. Current risk assessments are less effective for these individuals, necessitating improved strategies for managing suspected acute coronary syndrome.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Biomarkers

Background:

  • Elevated high-sensitive cardiac troponin T (hs-cTnT) is a significant predictor of poor outcomes in emergency department (ED) patients.
  • Acute coronary syndrome (ACS) is a critical diagnosis in the ED, often relying on hs-cTnT levels for risk stratification.

Purpose of the Study:

  • To evaluate the efficacy of an established ED risk assessment protocol in patients with suspected ACS and elevated baseline hs-cTnT.
  • To identify potential limitations of current risk stratification in this specific patient subgroup.

Main Methods:

  • An observational cohort study included 16,776 ED patients presenting with chest pain or dyspnea.
  • hs-cTnT levels were analyzed at the time of ED visit; 1,480 patients with elevated levels (>14 ng/L) were discharged.
  • Clinical, laboratory, and national health data were analyzed.

Main Results:

  • While overall mortality was low (1.2% for discharged, 11% for admitted), elevated hs-cTnT levels (>14 ng/L) were a strong independent risk factor for 90-day mortality (HR 3.3) among discharged patients.
  • Patients with hs-cTnT between 14-22 ng/L showed higher 90-day mortality whether discharged (4.1%) or admitted (6.7%).
  • Risk assessment was less effective for patients with hs-cTnT levels between 14-22 ng/L compared to those triaged as high-risk.

Conclusions:

  • The current ED risk assessment protocol demonstrates reduced effectiveness in patients with elevated hs-cTnT levels, particularly those with levels between 14-22 ng/L.
  • Improved risk stratification strategies are needed for emergency department patients with suspected ACS and elevated hs-cTnT to optimize patient outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
67
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
239
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
486
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
73
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
350
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
104